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Background: Describing the relationship between socioeconomic inequalities and cancer 
survival is important but methodologically challenging. We propose guidelines for addressing 
these challenges and illustrate their implementation on French population-based data.
Methods: We analyzed 17 cancers. Socioeconomic deprivation was measured by an ecological 
measure, the European Deprivation Index (EDI). The Excess Mortality Hazard (EMH), ie, the 
mortality hazard among cancer patients after accounting for other causes of death, was modeled 
using a flexible parametric model, allowing for nonlinear and/or time-dependent association 
between the EDI and the EMH. The model included a cluster-specific random effect to deal 
with the hierarchical structure of the data.
Results: We reported the conventional age-standardized net survival (ASNS) and described the 
changes of the EMH over the time since diagnosis at different levels of deprivation. We illus-
trated nonlinear and/or time-dependent associations between the EDI and the EMH by plotting 
the excess hazard ratio according to EDI values at different times after diagnosis. The median 
excess hazard ratio quantified the general contextual effect. Lip–oral cavity–pharynx cancer 
in men showed the widest deprivation gap, with 5-year ASNS at 41% and 29% for deprivation 
quintiles 1 and 5, respectively, and we found a nonlinear association between the EDI and the 
EMH. The EDI accounted for a substantial part of the general contextual effect on the EMH. 
The association between the EDI and the EMH was time dependent in stomach and pancreas 
cancers in men and in cervix cancer.
Conclusion: The methodological guidelines proved efficient in describing the way socio-
economic inequalities influence cancer survival. Their use would allow comparisons between 
different health care systems.
Keywords: cancer net survival, socioeconomic inequalities, European Deprivation Index, excess 
mortality hazard, flexible parametric model
Introduction
Assessing the relationship between socioeconomic deprivation and cancer survival is 
important as socioeconomic differences in cancer survival are still observed even in 
countries with universal health care coverages.1–6 Describing this relationship at the popu-
lation level calls for population-based cancer registry data, but the way of performing the 
analysis is challenging. Indeed, several methodological conditions should be met: 1) the 
use of a relevant measure of deprivation, usually ecological (ie, defined at an area level) 
as individual level of deprivation is not routinely collected in population-based data; 2) 
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the use of a relevant mortality indicator such as the excess 
disease-specific mortality among cancer patients vs noncancer 
subjects; 3) the use of a regression model able to deal first with 
nonlinear functional forms of the association between continu-
ous prognostic factors and the excess mortality (eg, between 
the deprivation index and the excess mortality throughout 
the range of the deprivation index values) and then deal with 
time-dependent associations (eg, nonconstant association 
between the deprivation index and the excess mortality over 
the time elapsed since diagnosis); 4) the use of an appropriate 
method for statistical inference that accounts for the statistical 
dependency between patients who share similar characteristics 
because they live in the same area across which the ecological 
deprivation index is defined (this is especially important when 
the interest lies in estimating regression parameters associated 
with the ecological deprivation variable);7–9 and 5) the use of a 
measure that summarizes the “importance” of the cluster level 
on the Excess Mortality Hazard (EMH).
Several recent ecological population-based stud-
ies addressing the question of the association between 
social deprivation and cancer survival were found in the 
 literature.4–6,10–12 Disease-specific mortality was generally 
the outcome of interest, usually estimated using an excess 
mortality approach, while cause-specific mortality approach 
was also used (using the cause of death). Statistical meth-
ods relied on either nonparametric or parametric regression 
modeling approaches. When modeling approaches were used, 
the adopted deprivation index was considered as a categori-
cal variable (quintiles). When regression models included 
the age at diagnosis as a prognostic factor, it was most of 
the time considered as a categorical variable. Finally, some 
studies explored the time-dependent associations between 
the variables and the hazard but it is not the rule, and none 
had taken into account the hierarchical structure of the data.
The present work proposes methodological guidelines 
for addressing the above-mentioned challenges (1–5) and 
illustrates their use through an investigation of the association 
between socioeconomic deprivation and cancer survival from 
solid tumor cancers up to 10 years after diagnosis. It is worth 
noticing that, although the article uses the term “effect” in a 
few places, no causal association is implied.
Materials and methods
Data
We used population-based cancer registry data that cover two 
contiguous Départements [French administrative areas] of 
West France (Calvados and Manche, nearly 1.1 million inhab-
itants). The quality and exhaustiveness of the included reg-
istries are certified every 4 years by an audit of the National 
Institute of Health and Medical Research (INSERM), the 
“Santé Publique France” agency, and the French National 
Cancer Institute. The incidence data from those registries 
are regularly included in the “Cancer Incidence in Five 
Continents” monograph series of the International Agency 
of Research on Cancer, where their quality and exhaustive-
ness are also assessed.
We analyzed cancer cases diagnosed between 1997 and 
2010 in people aged >15 years at diagnosis. The follow-up 
of all cases ended on June 30, 2013. The 17 cancers under 
study are displayed in Tables S1 and S2.
The data from these registries are not publicly available. 
We analyzed these data under the ethical approval obtained 
by each registry from the French institute “Commission 
Nationale de l’Informatique et des Libertés” (“998018” for 
the Calvados digestive cancer registry, “981001 V1” for 
the Calvados general cancer registry, and “912669” for the 
Manche cancer registry).
The measure of social deprivation
Because individual levels of deprivation are not routinely 
collected, ecological measures defined at area levels have 
been proposed.13,14 These measures are considered as good 
proxies of individual deprivation in relatively small areas15 
and measure additionally the patients’ social and economic 
environment (“contextual variables”).7,16,17
The European Deprivation Index (EDI) was developed 
using information from the European Union Statistics on 
Income and Living Conditions (EU-SILC) survey as well as 
other country-specific information.18 The ultimate goal of this 
index is to have in each European country an ecological depri-
vation index based on (country-specific) census variables 
using the same methodological approach for its construc-
tion while accounting for cultural and social specificities of 
each European country. The approach relies on the concept 
of relative deprivation, first proposed by the sociologist 
Peter Townsend.19 Deprivation refers to unmet fundamental 
needs caused by the lack of resources of all kinds (not only 
financial), those fundamental needs differing between soci-
eties (thus “relative” as it refers to deprivation specifically 
for a given society). Individuals can be said deprived when 
they lack the resources to obtain those types of needs (diet, 
type of living conditions, amenities, or services), which are 
obtained by the majority of people in the societies to which 
they belong to.
The EU-SILC is organized every year in every country 
of the EU-28. Based on a representative panel of European 
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household, individuals answer some detailed questions on 
their living condition in each country. The construction of 
the EDI can be summarized as follows: First, fundamental 
needs are identified for each European country using the EU-
SILC data. Among them, those associated with both objective 
poverty and subjective poverty are used to build a deprivation 
indicator at the individual level. Then, after identifying which 
variables are available at both the individual level (EU-SILC) 
and the area level (census), the area-level variables that are 
best correlated with the deprivation indicator built in the 
previous step are used to finally construct the area-based 
deprivation index. Details of concepts and construction meth-
ods are available in the previous methodologic papers.18,20
In France, this EDI is assigned to each IRIS (Îlot Regroupé 
pour l’Information Statistique, a geographical area of nearly 
2000 individuals); it was then assigned to each patient from 
a given IRIS. The correspondence between a patient and an 
IRIS was determined according to the patient’s address at 
the time of diagnosis. This used a Geographic Information 
System software (ArcGIS 10.2) and a street map database 
(BD TOPO premium). In this work, we used the EU-SILC 
from 2006 to derive the EDI, which ranges for France from 
−17.3 to 51.1 (quintile 1 [Q1]: [−17.3;−2.9], Q2: [−2.9;−1.4], 
Q3: [−1.4;0], Q4: [0;2.1], and Q5: [2.1;51.1]).
The Excess Mortality Hazard
A relevant disease-specific mortality indicator is needed. 
Cancer-specific mortality using the cause of death is very 
popular but hardly usable in our context. Actually, the cause 
of death may be inaccurate or unreliable, especially for long-
term studies, because it may be diversely coded over time and 
between regions. Besides, attributing a single cause of death 
to elderly people is debatable.21 Alternative approaches called 
“EMH methods” have been then developed;22–26 these do not 
require the knowledge of the cause of death.27–30 The basic 
idea of EMH methods is comparing the mortality between 
cancer patients and noncancer subjects with the same sex, 
age, and other main characteristics. The mortality of cancer-
free subjects, called “expected mortality”, is assumed to be 
correctly given by the general-population mortality, which 
is a known value. The EMH is then estimated by subtracting 
the expected mortality from the mortality of cancer patients; 
it provides the excess mortality due (directly or indirectly) to 
cancer at any time after diagnosis. For the expected mortality 
hazards, we used the French population mortality rates by sex, 
age (0–99 years), Département [French administrative area], 
and calendar year (1997–2013) as provided by the French 
Institut National de la Statistique et des Études Économiques.
From the EMH, we derived directly the net survival, using 
the classical relationship between hazard and survival. Net 
survival is then the probability of survival of cancer patients 
if the cancer under study was the only cause of death. In 
population-based studies, this key indicator allows com-
parisons between countries or periods and is not affected by 
differences in mortalities from other causes.31
Regression modeling of the EMH
In cancer patients, the relationship between a prognostic 
factor (such as EDI) and EMH may be complex.27,32,33 A 
multivariable regression model has to consider these com-
plex relationships using flexible functions.22,34 We defined 
a “full model” that modeled the EMH (on a log scale) as 
a function of time, age at diagnosis, year of diagnosis, and 
EDI, with these last three variables having time-dependent 
coefficients and nonlinear functional forms (thus leading 
to time-dependent and nonlinear log excess hazard ratios 
[EHRs], as denoted hereafter).
In addition, the EDI being an ecological variable and the 
individuals living in a given area sharing similar characteris-
tics (including the EDI variable), a specific statistical method 
should allow dealing with the hierarchical structure of the 
data (ie, multilevel data with dependence between individu-
als at each level).7–9 This was done by including a normally 
distributed random effect at the IRIS level.34
Thus, in formula, the “full model” for the EMH l
+
 is 
written as follows:
l
+
 (t, a, y, i|w) = l
0
 (t) exp(g(a) + h(t)a + j(y) +  
k(t)y + m(i) + n(t)i + w)
where l
0
(t) is the baseline hazard, a the age at diagnosis, y 
the year of diagnosis, i the EDI, and w the random effect 
defined at the IRIS level (with mean 0 and standard deviation 
s). The logarithm of the baseline hazard and the functions 
h, k, n were modeled with quadratic B-splines with knots 
located at 1 and 5 years, and the nonlinear functional forms 
g, j, m were modeled using quadratic splines with one knot 
(located at 70 years for age at diagnosis, at 2000 for the year 
of diagnosis, and at 0 for the EDI).
Finally, because the estimated standard deviation of the 
random effect per se is difficult to interpret, we summarized 
the “importance” of the cluster level on the EMH using the 
median excess hazard ratio (MEHR).35 This value reflects the 
influence of the cluster context as a whole, thus measuring 
the “general contextual effect”.17,35 The MEHR corresponds 
to the median relative change in the EMH when  comparing 
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identical subjects from two randomly selected different 
clusters that are ordered by risk.35
The analysis was separately conducted in men and women 
and used the iterative model-building strategy recommended by 
Wynant and Abrahamowicz.36 Starting with the “full model”, 
this strategy eliminates spurious time-dependent and nonlinear 
EHR functions of the three variables using the likelihood ratio 
test and 0.05 as significance threshold. This led to retain a final 
model for each sex-cancer couple. However, unlike the original 
proposal,36 we kept by default the simplest EHR (ie, linear and 
time-constant) for each of the three variables.
To implement the advocated statistical methods, we 
developed a specific package named mexhaz (version 1.1), 
which runs on R software (version 3.2.0). Both the software 
and the package may be freely downloaded from the CRAN 
repository (https://cran.r-project.org/).
Indicators produced
For each sex-cancer couple, we predicted from the final 
model the age-standardized net survival (ASNS) at 1, 5, 
and 10 years after diagnosis per deprivation quintile of the 
French population using the International Cancer Survival 
Standard weights.37 We used the delta method to derive the 
95% confidence intervals (CIs) for the ASNSs assuming the 
normality of the log of the cumulative excess hazard.
The change in the EMH over the time elapsed since 
diagnosis was illustrated for three values of age and three 
values of the EDI: the 10th, 50th, and 90th percentiles of 
each variable distribution observed in each sex-cancer couple.
When the EDI was retained in the final model with a time-
constant coefficient and a linear functional form, we reported 
the EHR for 1-unit increase of the EDI with its 95% CI. When 
the EDI was retained in the final model with time-constant 
coefficients and with a nonlinear form, we plotted the EHR vs 
the EDI values. When the EDI was retained in the final model 
with the time-dependent coefficient, we plotted the EHR vs 
the EDI values at various times after diagnosis. Because the 
sample size was usually small in this work, we focused on 
the effect size and its pattern rather than on the statistical 
significance in interpreting differences in function of the EDI.
For each sex-cancer couple, we calculated the MEHR with 
and without adjustment on the EDI from the final model to 
compare the general contextual effect on the EMH.
Results
Data description
Tables S1 and S2 display the number of cases and deaths over 
10 years after diagnosis. The highest numbers of deaths were 
found in deprivation quintiles Q4 and Q5 that group the most 
deprived people. These deaths represent almost 50% of all 
events in most cancers (Tables S1 and S2). A few sex-cancer 
couples were not analyzed because of the low number of deaths 
(<300 in each of esophagus, liver, and larynx cancers in women; 
breast cancer in men; and thyroid cancer in men and women).
Deprivation (EDI)
A constant-in-time EHR of the EDI with a linear functional 
form was retained in most cancer sites, except lip–oral 
cavity–pharynx (LOCP; nonlinear EHR in both sexes), 
stomach (time-dependent EHR), pancreas (nonlinear and 
time-dependent EHR) in men, and cervix uteri (nonlinear 
and time-dependent EHR; Table S3).
Five-year ASNS according to EDI
In men, a substantial difference in 5-year ASNS was seen 
between deprivation quintiles Q1 (the least deprived) and Q5 
(the most deprived) regarding LOCP cancers (41%; 95% CI: 
[38;43] vs 29% [27;31]). A similar difference was seen regard-
ing skin melanoma (87% [84;89] vs 76% [72;80]; Table 1). The 
difference in 5-year ASNS between Q1 and Q5 was nearly 7% 
for colon–rectum and bladder cancers, 6% for kidney, 5% for 
prostate cancer, 4% for lung and liver cancers, 3% for stomach 
and larynx cancers, and ≤2% for esophagus and pancreas can-
cers. Tables S4 and S5 show the results of 1- and 10-year ASNS 
by deprivation quintile. For pancreas cancer, the absence of the 
impact of EDI on the 5-year ASNS contrasts greatly with the 
substantial difference observed in 1-year ASNS (36% [33;40] 
in Q1 vs 25% [22;28] in Q5) (Table S4). This is due to a special 
time-dependent EHR of the EDI that we explain later.
In women, as in men, a substantial difference in 5-year 
ASNS was observed between Q1 and Q5 regarding LOCP 
cancers, 55% [49;62] vs 43% [39;47], with a higher predicted 
ASNS for Q2 (60% [56;64]) than Q1. The difference in 5-year 
ASNS between Q1 and Q5 was around 6% for bladder cancer; 
4% for breast and melanoma cancers; 3% for colon–rectum, 
lung, and ovary cancers; and ≤2% for CNS, pancreas, and 
stomach cancers. In contrast, for cervix uteri, the 5-year 
ASNS was lower in the less deprived women in comparison 
with the most deprived: 55% [51;59] for Q1 vs 64%–66% 
for the other quintiles. This pattern was also found for 1- and 
10-year ASNS (Tables S4 and S5) for that cancer site.
Changes over time since diagnosis of the EMH 
according to EDI and age, and complementary 
illustrations of the relationship between EDI and EMH
The changes of the EMH over the time elapsed since diagnosis 
are given for three values of age and three values of EDI (the 
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10th, 50th, and 90th percentiles) for 1) LOCP in men, LOCP in 
women, and melanoma in men (Figure 1); 2) pancreas and stom-
ach in men and cervix uteri (Figure 2); and 3) all other cancer 
sites (Figures S1–S4). Marked differences were seen by age at 
diagnosis; the EMHs were higher in old than in young patients, 
especially during the first year(s) after diagnosis. Changes of 
the EMH over time since diagnosis illustrate how and when the 
EDI impact takes place across the follow-up at specific ages 
at diagnosis and complement the previously given net survival 
results. For example, the graphs allow illustrating the strong 
association between the EDI and the EMH for LOCP cancer 
in both sexes: the curve is always higher in deprived people. A 
quick look at the graphs might give the false impression that 
the EHR of the EDI depends on time (see the middle box in 
Figure 1 where the curves are not parallel for LOCP in women 
aged 61.5 years). This is because the hazards are proportional 
on the log-scale, whereas the graphs use an arithmetic scale. 
On an arithmetic scale, a value of a time-constant EHR of 2, 
for example, will display a larger difference between hazards 
when the baseline hazard is high rather than low.
For LOCP cancers in both sexes, the model-building 
strategy retained a nonlinear functional form (though time-
constant) for the log-EHR of the EDI (Table S4). In men, the 
EHR increased according to EDI values but then plateaued in 
the more deprived people (Figure 3A); however, in women, 
a plateau is seen in both the least and the most deprived 
people (Figure 3B).
We also observed a substantial association between the 
EDI and the EMH in melanoma in men (bottom plots of 
Figure 1): the retained EHR of EDI was constant in time 
with a linear functional form (Table S3).
For stomach cancer in men, we observed higher EMHs 
in deprived patients starting from 5 years after diagnosis 
( Figure 2, upper plots), and thus, weak differences between 
Q1 and Q5 regarding 1- and 5-year ASNS (Table 1 and 
Table S4) but a substantial difference (11%) regarding 
10-year ASNS (Table S5). Figure 4A shows the time-
dependent EHR of the EDI in stomach cancer, especially 
a substantial impact in late follow-up (5 years), even if the 
EMHs are quite low after 5 years (Figure 2).
Figure 1 Changes over time since diagnosis of the excess mortality hazard for the 10th, 50th, and 90th percentiles of the age distribution (left, middle, and right column, 
respectively) and for the 10th, 50th, and 90th percentiles of the EDI distribution (curves with black circles, red triangles, and green crosses, respectively) regarding LOCP in 
men and women, and melanoma in men; patients diagnosed in 2010.
Abbreviations: EDI, European Deprivation Index; LOCP, lip–oral cavity–pharynx.
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For pancreas cancer in men, we observed a very complex 
pattern associated with the EDI, especially a lower EMH 
within the first year in the less deprived patients vs other 
patients and, in contrast, a lower EMH between years 1 and 
4 in deprived vs less deprived patients. Therefore, the impact 
of deprivation on net survival was high over the first year 
after diagnosis and resulted in a substantial difference in 
1-year ASNS between the less deprived to the other patients 
(Table S4). This difference shrunk at 5 years because of the 
reverse association observed after 1 year (Figure 4B). At 6 
months, the EHR is <1 at small EDI values (ie, in the less 
deprived patients) and ~1 at other values. At 3 years, the 
EHR is slightly >1 in the less deprived patients and slightly 
<1 in the more deprived (Figure 4B). At 5 years, the EHR 
should be interpreted with caution because the prognosis of 
pancreas cancer at 5 years is rather poor, and thus, the number 
of patients still at risk is rather low.
Finally, for cervix uteri cancer, the EMH was higher in 
the less deprived people than in people with a median EDI 
whatever the time since diagnosis and the age at diagnosis 
(Figure 2). Therefore, the 1-, 5-, and 10-year ASNS was lower 
in the less deprived people than in others (Tables 1, S4, and 
S5). This corresponds to very complex nonlinear and time-
dependent EHRs of the EDI (Figure 4C), the main informa-
tion relying on the U-shape of the curves (ie, EHRs >1 were 
observed in the least and the most deprived people).
General contextual effect
The MEHRs with and without adjustment on the EDI are 
given in Table S6. For LOCP cancers in men, the median 
increase in the EMH between similar patients from IRIS 
with a high vs a low excess mortality was 25.5% before 
adjustment on the EDI (MEHR=1.255) and 21.4% after 
adjustment (MEHR=1.214).35 The figures in women were 
also substantial: the median increase in the EMH was 23.8% 
before adjustment vs 8.1% after adjustment. This reveals an 
important general contextual effect for LOCP cancers; the 
EDI seems to explain an important part of EMH variability 
between IRIS, especially in women. We also observed an 
important decrease (before vs after adjustment on the EDI) 
Figure 2 Changes over time since diagnosis of the excess mortality hazard for the 10th, 50th, and 90th percentiles of the age distribution (left, middle, and right column, 
respectively) and for the 10th, 50th, and 90th percentiles of the EDI distribution (curves with black circles, red triangles, and green crosses, respectively) regarding stomach 
and pancreas cancers in men, and cervix uteri; patients diagnosed in 2010.
Abbreviation: EDI, European Deprivation Index.
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of the MEHR for prostate, melanoma, and pancreas cancers 
in men (Table S6).
Discussion
In an international context of increasing socioeconomic 
inequalities,38 describing and quantifying the association 
between socioeconomic inequalities and the excess cancer-
related mortality hazard is important. Here, we used a strategy 
able to deal with specific methodological requirements: the 
use of a relevant measure of deprivation and a relevant mor-
tality indicator (the EMH) estimated using a flexible regres-
sion model able to deal with nonlinear and time-dependent 
associations. The approach should account for the fact that 
individuals within a cluster share similar characteristics and 
should also allow to summarize the “importance” of the clus-
ter level on the EMH. We applied this approach to 17 solid 
tumors diagnosed in a specific area of France and followed 
up over 10 years after diagnosis to investigate the change over 
time of the excess mortality by age and socioeconomic level. 
We summarize the recommendations we believe important to 
describe the association between socioeconomic deprivation 
and the EMH (Table 2).
Using population-based cancer registry data ensures 
depicting the full picture of cancer survival inequalities. For 
decades, the notifications of cancer cases come from many 
different sources (public and private pathology laboratories 
and hospital discharge databases as well as databases of 
the National Health System). Even if the number of data 
sources has dramatically increased since 1997, it was to col-
lect further information on cancer cases such as treatment, 
thus not affecting the core of the cancer registry data and 
their exhaustiveness. For these reasons, we do not suspect 
any differential ascertainment over the study time period 
nor between areas of residence or individual and area-level 
socioeconomic determinants. We used the EDI to quantify 
the deprivation as this index was built to be reproducible in 
European countries.18 We assumed that 1) the EDI assigned 
to each IRIS remains constant from 1997 to 2010, and 2) the 
patient’s deprivation corresponds to the EDI measured at the 
time of diagnosis (no misclassification). We considered these 
assumptions reasonable because 1) the crude level of the EDI 
has little significance per se: it is more the ranking of each 
IRIS across the overall distribution which is of interest and 
this ranking is less influenced by time, and 2) the number of 
patients moving after the diagnosis of cancer, which can be 
seen as a misclassification problematic, should be low for 
different reasons (access to cancer treatment, preservation 
of social network, etc). Bryère et al showed that the bias of 
such misclassification on the association between deprivation 
and cancer incidence was minimal in their study context.39 
However, more research should be conducted in the context 
of deprivation and cancer survival.
We recommend using flexible parametric regression mod-
els and underline the importance of examining the changes of 
the EMH over time since diagnosis together with the net sur-
vival (Figures 1 and 2) and the EHRs (Figures 3 and 4); this 
ensures relevant and complementary clinical information.40–43 
Indeed, at a given time t, the probability of net survival is a 
cumulative measure up to time t, whereas the EMH gives an 
instantaneous picture of what happens specifically at time t. It 
quantifies the instantaneous rate at which subjects experience 
an excess death (given they survived up to t) and, being a rate, 
the EMH may be >1. When the EMH is low (say <0.1) and 
practically constant over the year, its value is very close to 
the annual probability of death from the disease. With higher 
values, a back-transformation on the probability scale (using 
Figure 3 Excess hazard ratio of the EDI on lip–oral cavity–pharynx cancer in men 
(A) and women (B) with 95% confidence intervals (shaded area).
Notes: We limited the EDI values on the x-axis to the 5th and 95th percentiles 
of the observed EDI distribution in the sex-cancer couple. Rug plots indicate the 
locations of the observed EDI values.
Abbreviation: EDI, European Deprivation Index.
1.
4
1.
2
1.
0
0.
8
–4 –2 0 2
European Deprivation Index
A Men
E
xc
es
s 
ha
za
rd
 ra
tio
4 6 8
2.
5
2.
0
1.
5
1.
0
–4 –2 0 2
European Deprivation Index
B Women
E
xc
es
s 
ha
za
rd
 ra
tio
4 6 8
 
Cl
in
ica
l E
pi
de
m
io
lo
gy
 d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
4.
80
.2
29
.2
44
 o
n 
07
-J
un
-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Clinical Epidemiology 2018:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
569
Socioeconomic inequalities and cancer survival
the classical relationship between hazard and survival) may 
be advantageous for clinical interpretation because it provides 
a conditional probability.
Caution should be taken when interpreting the changes 
of the EMH over time because its decrease in a population 
(“marginal” EMH) could be due either to true decreases of 
individual EMHs or to a “selection effect” over time.44 For 
example, when a population includes a mix of 1) patients 
with localized cancer stages and low and constant-in-time 
EMH and 2) patients with advanced stages and high and 
constant-in-time EMH, the analysis of this population as a 
whole (in the absence of information on stage) will estimate 
a “marginal” EMH that will decrease with time. The more 
“frail” individuals (with the higher hazards) will die early, 
Figure 4 Excess hazard ratio of the EDI at different times after diagnosis for stomach (A) and pancreas (B) cancers in men and cervix uteri (C) cancer in women.
Notes: We limited the EDI values on the x-axis to the 5th and 95th percentiles of the observed EDI distribution in the sex-cancer couple. Rug plots indicate the locations 
of the observed EDI values.
Abbreviation: EDI, European Deprivation Index.
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whereas the more “robust” individuals (with the lower haz-
ards) will stay at risk (are “not selected to die”): the marginal 
EMH will then decrease and approach the EMH of the more 
robust subjects.44 Nevertheless, the possibility to estimate 
and depict those quantities (EMH and EHR) over time using 
flexible functional forms is an important advantage of our 
proposed methodology compared to using a simpler model 
with either shape-restricted baseline hazard (such as mono-
tonic for the Weibull distribution) or assuming proportional 
hazard ratio. As an illustration, we fitted a simple model 
without a random effect and assumed a Weibull distribution 
and linear and proportional hazard ratios for each prognostic 
factor. We applied this simple model to the LOCP cancer 
in men and in women, and to pancreas cancer in men. In 
LOCP cancers, using this simple model would not allow to 
identify the plateau of the EHR for the most deprived men 
nor both plateaus for the less deprived and the most deprived 
women (Figure 3). From this simple model, the estimated 
EHR comparing women with EDI=4 to women with EDI=0 
was 1.21 [1.09;1.34] compared to 1.50 [1.19;1.90] with our 
approach. Neglecting the time-dependent effect of the EDI 
for pancreas cancers with the simple model would also lead 
to a substantial oversimplification, showing no evidence of 
an association between the EDI and the EMH (EHR for 1- 
unit increase of the EDI=1.00 [0.98;1.022]), compared to the 
complex time-varying association found with our approach 
(Figure 4B).
We advocated the use of a model-building strategy to 
eliminate spurious time-dependent and nonlinear EHR 
functions from a flexible regression model. We used the one 
proposed by Wynant and Abrahamowicz,36 but an alternative 
model-building strategy could be used, such as the one pro-
posed by Royston and Sauerbrei.45 However, the development 
of algorithms for model building is still an active area of sta-
tistical research, and studies comparing the ability of model-
building strategies to eliminate spurious time-dependent and 
nonlinear EHR functions would be useful for giving advice 
to the analyst. Whatever the choice of the model-building 
strategy, fitting regression models requires observing enough 
events for providing reliable estimates, and this may be an 
issue in small sample studies or when studying cancer with 
a very good prognosis. In our work, we did not analyze some 
sex-cancer couples because of insufficient observed events 
for fitting the “full model” based on the “rule” of observing 
at least 10 events per parameters,46 even though this “rule” 
is still debatable.47
We evidenced an association (linear and constant-in-
time) between the EDI and the EMH in colon–rectum, lung, 
melanoma, and prostate cancers in men as in breast cancer 
in women, with lower survivals in the most deprived. We 
also found a substantial deprivation gap in LOCP cancers in 
both sexes with >10% differences in 5-year ASNS between 
deprivation Q1 and Q5. The main drivers of LOCP cancer are 
alcohol and tobacco consumptions, and both are associated 
Table 2 Summary of the guidelines for describing the association between socioeconomic inequalities and cancer survival
Step Guidelines
Data
•	 Use data from a source that provides an unbiased picture of the whole population, such as population-based registries data
•	 Use an appropriate ecological deprivation measure, which can be 1) replicated in other countries (for comparison purposes); 
and 2) based on as small geographical unit as possible
Method
•	 Define the excess mortality hazard as your main quantity of interest
•	 Use general-population lifetables for the expected mortality hazard and the deprivation-specific ones whenever possible
•	 Use flexible parametric multivariable regression models, which enable modeling nonlinear as well as time-dependent log excess 
hazard ratios for prognostic factors (such as the deprivation index)
•	 Take account of the multilevel/hierarchical structure of the data to derive correct statistical inference
•	 Use a model-building strategy or an information criterion to eliminate spurious nonlinear and time-dependent log excess hazard 
ratios
Results
•	 Provide model-predicted age-standardized net survivals by deprivation quintile and compare them to the nonparametric 
estimates (to check the goodness of fit of the model)
•	 Give additional and clinically relevant information from the modeling approach: 1) the change with time since diagnosis of 
the excess mortality hazard for different values of the deprivation index and 2) the excess hazard ratios for the association 
(eventually nonlinear and/or time-dependent) between the EDI and the excess mortality hazard
•	 Quantify the impact of clustering on the excess mortality hazard using the general contextual effect and (whenever possible) an 
intraclass correlation coefficient
Abbreviation: EDI, European Deprivation Index.
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with other comorbidities; this limits the treatment possibili-
ties and leads to poor prognoses. In France, the prevalence 
of tobacco smokers in men or women is generally higher in 
deprived than in most affluent people though women with 
management responsibilities seem more prone to smoking 
than others.48,49 Regarding alcohol consumption, the picture 
is more complex and differs with sex: excessive alcohol con-
sumption is more frequent among women with management 
responsibilities vs other women but affects both extremes of 
the deprivation scale in men.48 In addition, the probability 
of alcohol avoidance is quite high among deprived people.48 
These observations are in line with the patterns of the EHR 
of the EDI (Figure 3A and B).
For stomach cancer in men, deprived patients were found 
exposed to a higher excess mortality at 5 years after diagnosis 
vs less deprived patients, whereas the EDI plays no role at 
1 or 3 years after diagnosis (Figure 4A). This may be due 
to 1) more comorbidities among deprived patients that may 
preclude the recourse to the best treatment strategies and 
lead to higher risks of relapse in the long term and/or 2) 
lower patient adherence to cancer follow-up among deprived 
patients. For cervix uteri, we showed a higher excess mortal-
ity among the less deprived patients (Figure 4C): it may be 
linked to a higher participation to cervical screening among 
the less deprived subjects,50 which would eliminate a higher 
number of curable precancerous lesions in affluent than in 
deprived people.
The interpretation of such relationships would benefit 
from additional information on cancer stage at diagnosis and 
comorbidities. Such data were not available for the present study 
but French registries have started the systematic collection of 
stage at diagnosis. Another limitation of the study is the lack of 
deprivation-specific expected mortality rates in France. There-
fore, the use of the general-population mortality as expected 
mortality rate overestimates the excess hazard in the more 
deprived people (because their expected mortality is usually 
higher than the “average” mortality in the general population) 
and underestimates it in the less deprived ones. This may lead 
to amplify the impact of the EDI and highlight the urgent need 
to produce deprivation-specific life tables in France.
In the present article, we predicted the ASNSs from the 
fitted regression model and obtained the ASNSs even in case 
of sparse data because model-predicted NSs can be obtained 
after the date of the last event in a specific stratum (which 
is another advantage of using our proposed methodology 
compared to using only nonparametric estimates). However, 
these predictions rely on the assumption that the regression 
model is correctly specified. For each sex-cancer couple, we 
checked the goodness of fit of the model by comparing the 
model-based ASNS with the nonparametric ASNS as given 
by the Pohar-Perme estimator24 for each deprivation quintile 
and each period of diagnosis ([1997–2000], [2001–2005], 
[2006–2010], and all periods combined). Comparing the 
5-year ASNSs showed the good accuracy of model-based 
NS prediction (Figure S5).
Quantities that measure between- and within-cluster 
variability may help interpreting the results. We extended the 
median hazard ratio proposed by Austin and Merlo35 to our 
context of EMH to reach a better understanding of the impact 
of a within-IRIS clustering on the EMH. According to these 
authors, one would additionally compare the MEHR to the 
estimated EHR of each prognostic factor. However, in our 
final explanatory model, we rarely retained a single parameter 
for each prognostic factor, which makes impossible such a 
comparison. So, though the MEHR has the merit of simplic-
ity, an interesting perspective would be to extend the approach 
proposed by Oliveira et al.51 These authors derived an intra-
class correlation coefficient for time-to-event regression 
models with a random effect (frailty). As in a linear model, 
this coefficient is defined as a ratio of variance components, 
which allows interpreting the coefficient as the proportion 
of the total variance due to the between-IRIS variability.52 
However, the approach proposed by Oliveira et al suits their 
specific models that include closed forms of marginal vari-
ance, which leads to closed forms of intraclass correlation.51 
A future work would check whether their approach may be 
applied to our model.
Evaluating the interactions between prognostic factors 
is a further important step when describing the association 
between deprivation and cancer survival. For example, the 
interactions allow checking whether the EHR of the EDI is 
the same whatever the age at diagnosis. In an exploratory 
analysis that used Royston and Sauerbrei’s methodology45 to 
study interaction, our preliminary results suggested that such 
interactions do exist for some cancers (results not shown). 
These results still need a validation of a robust statistical 
approach to test the interactions. Another important research 
area would be to extend this analysis by including socioeco-
nomic measures defined at both the individual level and the 
area level. Indeed, with the EDI being an ecological variable,53 
the estimated effect of deprivation actually combines indi-
vidual and contextual effects. Adjusting for both subject- and 
area-specific measures would allow disentangling individual 
from contextual effects of deprivation.16,54–56
International comparisons of the association between 
socioeconomic deprivation and cancer survival are useful to 
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understand differences between health care systems. Several 
studies have already reported poorer prognoses in deprived 
vs less deprived cancer patients.2,4–6,57 However, comparing 
the results is difficult because of distinct study designs, sta-
tistical analysis methods, and deprivation indexes. We hope 
the proposed approach will provide a methodological basis 
for such explorations. The use of the present approach with 
the EDI in other European countries20 will ease comparisons 
between European health care systems.
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